Abstract
In 2011, the US Food and Drug Administration (FDA) approved Makena (hydroxyprogesterone caproate) for the prevention of preterm birth (PTB) in pregnan......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
